{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:04:43Z","timestamp":1765778683741,"version":"3.48.0"},"reference-count":38,"publisher":"CSIRO Publishing","issue":"5","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":1735,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,30]]},"abstract":"\n Objective<\/jats:title>\n The aim of this study was to identify the hepatitis C treatment intentions of Aboriginal people living with hepatitis C virus (HCV) in Western Australia.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n This study used a mixed-methods design. In the cross-sectional survey, 123 Aboriginal people who inject drugs and self-report as living with hepatitis C completed a purpose-designed questionnaire. In the qualitative phase, 10 participants were interviewed about the factors influencing their future intentions to undertake hepatitis C treatment.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Analysis of the survey data revealed significant associations between an intention to undertake hepatitis C treatment and support, community attachment, stable housing and stigma. In addition, there was a high overall level of expressed intention to undertake HCV treatment, with 54% of participants responding positively. Analysis of the qualitative data supported quantitative findings, revealing concerns about stigma, lack of social support and unstable housing as factors affecting the intention to undertake hepatitis C treatment.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n This mixed methods study with Aboriginal people living with self-reported HCV indicates interventions focused on reducing stigma and unstable housing could positively affect hepatitis C treatment intentions. These findings have implications for developing holistic programs to promote and support people on hepatitis C treatment.<\/jats:p>\n <\/jats:sec>\n \n What is known about the topic?<\/jats:title>\n Substantial knowledge gaps need to be resolved if HCV elimination among Aboriginal Australians is to be achieved. Current research has prioritised non-Aboriginal communities.<\/jats:p>\n <\/jats:sec>\n \n What does this paper add?<\/jats:title>\n This study found that stigma and unstable housing require attention if Aboriginal Australians are to obtain the full benefits of direct acting antiviral (DAA) hepatitis C treatment.<\/jats:p>\n <\/jats:sec>\n \n What are the implications for practitioners?<\/jats:title>\n Reducing stigma (in the primary healthcare setting) and providing access to stable housing are vital components of supportive, non-judgemental and culturally appropriate care for Aboriginal people. This study highlights the importance of education for nurses and other primary care providers to increase engagement in the hepatitis cascade of care. To achieve this, scaling-up of HCV treatment engagement, trained Aboriginal community healthcare workers and HCV treatment advocates must mobilise and support Aboriginal people to avoid the negative effects of stigma, build positive and enabling relationships and reinforce positive attitudes towards DAA hepatitis C treatment.<\/jats:p>\n <\/jats:sec>","DOI":"10.1071\/ah19194","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T04:25:56Z","timestamp":1598588756000},"page":"755-762","source":"Crossref","is-referenced-by-count":11,"title":["Factors affecting hepatitis C treatment intentions among Aboriginal people in Western Australia: a mixed-methods study"],"prefix":"10.1071","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7355-5216","authenticated-orcid":true,"given":"Amineh","family":"Rashidi","sequence":"first","affiliation":[{"name":"ASchool of Nursing and Midwifery, Building 21, Room 409, Edith Cowan University, Joondalup Campus, WA 6207, Australia."},{"name":"DCorresponding author. Email: a.rashidi@ecu.edu.au"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5587-5379","authenticated-orcid":true,"given":"Peter","family":"Higgs","sequence":"additional","affiliation":[{"name":"BDepartment of Public Health, La Trobe University, Plenty Road, Bundoora, Vic. 3083, Australia. Email: P.Higgs@latrobe.edu.au"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Carruthers","sequence":"additional","affiliation":[{"name":"CPeer Based Harm Reduction WA, Bunbury Site, Suite 21 & 22, 7 Aberdeen Street,\u2009Perth, WA 6230, Australia. Email: swcdw@harmreductionwa.org"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"67","published-online":{"date-parts":[[2020,8,28]]},"reference":[{"key":"2025121501001579800_R1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/add.14393","article-title":"Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs.","volume":"114","author":"Grebely","year":"2019","journal-title":"Addiction"},{"key":"2025121501001579800_R2"},{"key":"2025121501001579800_R3","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/1471-2458-14-201","article-title":"Gaps in Indigenous disadvantage not closing: a census cohort study of social determinants of health in Australia, Canada, and New Zealand from 1981\u20132006.","volume":"14","author":"Mitrou","year":"2014","journal-title":"BMC Public Health"},{"key":"2025121501001579800_R4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0140-6736(09)60914-4","article-title":"Indigenous health part 1: determinants and disease patterns.","volume":"374","author":"Gracey","year":"2009","journal-title":"Lancet"},{"key":"2025121501001579800_R5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2055102915601581","article-title":"The role of Aboriginal community attachment in promoting lifestyle changes after hepatitis C diagnosis.","volume":"2","author":"Brener","year":"2015","journal-title":"Health Psychol Open"},{"key":"2025121501001579800_R6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/1753-6405.12231","article-title":"Cultural respect strategies in Australian Aboriginal primary health care services: beyond education and training of practitioners.","volume":"38","author":"Freeman","year":"2014","journal-title":"Aust N Z J Public Health"},{"key":"2025121501001579800_R7"},{"key":"2025121501001579800_R8"},{"key":"2025121501001579800_R9"},{"key":"2025121501001579800_R10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/1753-6405.12741","article-title":"Hepatitis C virus prevalence and associated risk factors among Indigenous Australians who inject drugs.","volume":"42","author":"Doyle","year":"2018","journal-title":"Aust N Z J Public Health"},{"key":"2025121501001579800_R11"},{"key":"2025121501001579800_R12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jhep.2019.04.014","article-title":"Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.","volume":"71","author":"Alavi","year":"2019","journal-title":"J Hepatol"},{"key":"2025121501001579800_R13"},{"key":"2025121501001579800_R14","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/j.1467-842X.2006.tb00457.x","article-title":"Now, later or never? Challenges associated with hepatitis C treatment.","volume":"30","author":"McNally","year":"2006","journal-title":"Aust N Z J Public Health"},{"key":"2025121501001579800_R15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/09540120412331299834","article-title":"Trends and predictors of HIV-positive community attachment among PLWHA.","volume":"17","author":"Rawstorne","year":"2005","journal-title":"AIDS Care"},{"key":"2025121501001579800_R16"},{"key":"2025121501001579800_R17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1207\/s15327752jpa5201_2","article-title":"The multidimensional scale of perceived social support.","volume":"52","author":"Zimet","year":"1988","journal-title":"J Pers Assess"},{"key":"2025121501001579800_R18","doi-asserted-by":"crossref","DOI":"10.5334\/ijic.819","article-title":"Evaluation of an integrated care service facility for people living with hepatitis C in New Zealand.","volume":"12","author":"Horwitz","year":"2012","journal-title":"Int J Integr Care"},{"key":"2025121501001579800_R19","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/j.1465-3362.2012.00468.x","article-title":"Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs.","volume":"31","author":"Treloar","year":"2012","journal-title":"Drug Alcohol Rev"},{"key":"2025121501001579800_R20","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/jvh.12415","article-title":"Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: the ETHOS study.","volume":"22","author":"Alavi","year":"2015","journal-title":"J Viral Hepat"},{"key":"2025121501001579800_R21","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/j.1465-3362.2012.00468.x","article-title":"Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs.","volume":"31","author":"Treloar","year":"2012","journal-title":"Drug Alcohol Rev"},{"key":"2025121501001579800_R22"},{"key":"2025121501001579800_R23","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1155\/2008\/320150","article-title":"Outcomes of peginterferon alpha-2a and ribavirin hepatitis C therapy in Aboriginal Canadians.","volume":"22","author":"Cooper","year":"2008","journal-title":"Can J Gastroenterol"},{"key":"2025121501001579800_R24","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1111\/1753-6405.12402","article-title":"Experiences of diagnosis, care and treatment among Aboriginal people living with hepatitis C.","volume":"40","author":"Brener","year":"2016","journal-title":"Aust N Z J Public Health"},{"key":"2025121501001579800_R25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207226","article-title":"Beyond interferon side effects: what residual barriers exist to DAA hepatitis C treatment for people who inject drugs?","volume":"13","author":"Madden","year":"2018","journal-title":"PloS One"},{"key":"2025121501001579800_R26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/13557858.2015.1004870","article-title":"Care and treatment of hepatitis C among Aboriginal people in New South Wales, Australia: implications for the implementation of new treatments.","volume":"21","author":"Treloar","year":"2016","journal-title":"Ethn Health"},{"key":"2025121501001579800_R27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.addbeh.2017.08.036","article-title":"Implicit and explicit internalized stigma: relationship with risky behaviors, psychosocial functioning and healthcare access among people who inject drugs.","volume":"76","author":"von Hippel","year":"2018","journal-title":"Addict Behav"},{"key":"2025121501001579800_R28","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1037\/amp0000068","article-title":"Structural stigma and health inequalities: research evidence and implications for psychological science.","volume":"71","author":"Hatzenbuehler","year":"2016","journal-title":"Am Psychol"},{"key":"2025121501001579800_R29","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1037\/0022-3514.84.5.1079","article-title":"The role of racial identity in perceived racial discrimination.","volume":"84","author":"Sellers","year":"2003","journal-title":"J Pers Soc Psychol"},{"key":"2025121501001579800_R30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.drugpo.2019.08.003","article-title":"\u2018Another thing to live for\u2019: supporting HCV treatment and cure among Indigenous people impacted by substance use in Canadian cities.","volume":"74","author":"Pearce","year":"2019","journal-title":"Int J Drug Policy"},{"key":"2025121501001579800_R31","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1089\/apc.2010.0142","article-title":"Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration.","volume":"24","author":"Swan","year":"2010","journal-title":"AIDS Patient Care STDS"},{"key":"2025121501001579800_R32","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/MEG.0b013e32832a8c4c","article-title":"Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support.","volume":"22","author":"Grebely","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2025121501001579800_R33","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/COH.0b013e32834bcb36","article-title":"Management of HCV and HIV infections among people who inject drugs.","volume":"6","author":"Grebely","year":"2011","journal-title":"Curr Opin HIV AIDS"},{"key":"2025121501001579800_R34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-7517-10-7","article-title":"Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors.","volume":"10","author":"Harris","year":"2013","journal-title":"Harm Reduct J"},{"key":"2025121501001579800_R35","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1111\/jvh.13175","article-title":"Treatment adherence and support for people who inject drugs taking direct-acting antiviral therapy for hepatitis C infection.","volume":"26","author":"Read","year":"2019","journal-title":"J Viral Hepat"},{"key":"2025121501001579800_R36","article-title":"Adherence to once-daily and twice-daily direct-acting antiviral therapy for hepatitis C infection among people with recent injection drug use or current opioid agonist therapy.","author":"Cunningham","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2025121501001579800_R37","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.drugpo.2019.03.017","article-title":"Hepatitis C treatment outcomes among homeless-experienced individuals at a community health centre in Boston.","volume":"72","author":"Beiser","year":"2019","journal-title":"Int J Drug Policy"},{"key":"2025121501001579800_R38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s41124-016-0016-6","article-title":"Concordance between self-reported and measured HIV and hepatitis C virus infection status among people who inject drugs in Germany.","volume":"1","author":"Nielsen","year":"2016","journal-title":"Hepatol Med Policy"}],"container-title":["Australian Health Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/ah\/article-pdf\/44\/5\/755\/439311\/ah19194.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/ah\/article-pdf\/44\/5\/755\/439311\/ah19194.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:00:23Z","timestamp":1765778423000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/ah\/article\/44\/5\/755\/70901\/Factors-affecting-hepatitis-C-treatment-intentions"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,28]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9,30]]}},"URL":"https:\/\/doi.org\/10.1071\/ah19194","relation":{},"ISSN":["0156-5788","1449-8944"],"issn-type":[{"type":"print","value":"0156-5788"},{"type":"electronic","value":"1449-8944"}],"subject":[],"published":{"date-parts":[[2020,8,28]]}}}